EMA to release adverse drug reactions reports

The European Medicines Agency (EMA) will release documents related to withdrawn acne treatment Roaccutane (Accutane-U.S.) isotretinoin from Roche (SIX:ROG; OTCQX:RHHBY) after the European Ombudsman ca...